Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: Clin Cancer Res. 2017 Jan 20;23(13):3343–3351. doi: 10.1158/1078-0432.CCR-16-2745

Figure 4. Estimated absorption dose of 90Y-DOTA-AR in PC-3 xenografts.

Figure 4

(A) The estimated dose ratio between 90Y-DOTA-AR and combination of 90Y-DOTA-AR/VTP is depicted. (B) The table shows the summary statistics for both treatment groups. Both mean and median radiation doses were higher for 90Y-DOTA-AR and VTP. Twenty four denotes radiation dose delivered ≥ 24 hours p.i.